Description
Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.
Product information
CAS Number: 1454288-88-0
Molecular Weight: 452.45
Formula: C21H19F3N2O4S
Chemical Name: ethyl 2-(5-{3'-methanesulfonyl-[1,1'-biphenyl]-4-yl}-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetate
Smiles: CCOC(=O)CN1N=C(C=C1C1C=CC(=CC=1)C1=CC(=CC=C1)S(C)(=O)=O)C(F)(F)F
InChiKey: ZUMNJDGBYXHASJ-UHFFFAOYSA-N
InChi: InChI=1S/C21H19F3N2O4S/c1-3-30-20(27)13-26-18(12-19(25-26)21(22,23)24)15-9-7-14(8-10-15)16-5-4-6-17(11-16)31(2,28)29/h4-12H,3,13H2,1-2H3
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Solubility: To be determined
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
How to use
In Vitro:
Rovazolac is an anti-inflammatory drug candidate.
References:
- Mohan R. Preparation of substituted pyrazoles as liver X receptor (LXR) modulators useful for the treatment of dermal diseases, disorders and conditions. WO2013130892A1
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.